Clinical Trial of CNS-targeted HAART (CIT2)
NCT00624195
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
FDA Approved Antiretroviral Therapy (see list below)
Sponsor
University of California, San Diego
Collaborators
[object Object]
[object Object]